Moffitt Cancer Center at IDWeek 2026

Oct 21–24, 2026 Washington, DC ~12k attendees Website

Moffitt Cancer Center brings 2 presentations to IDWeek 2026 in Washington. Its program centres on infections in cancer patients receiving cellular therapies and transplants. It describes infectious complications after lifileucel tumor-infiltrating lymphocyte therapy for melanoma and the use of crushed letermovir in hematopoietic cell transplant and cellular therapy patients.

OrganizationIDWeek 2026 Attendance
Poster
Fri Oct 23
12:15pm–1:30pm
Infectious Complications in Patients with Metastatic Melanoma Treated with Lifileucel, Tumor-Infiltrating Lymphocyte (TIL) Therapy: A Single Center Retrospective Study
Poster Hall B-C · Poster P-2029
T3. Studies of the epidemiology of infections in transplant patients and patients with impaired immunity due to underlying disease or immunosuppressive drugs
Poster
Fri Oct 23
12:15pm–1:30pm
Utilization of Crushed Letermovir in Allogeneic Hematopoietic Cell Transplant and Cellular Therapies
Poster Hall B-C · Poster P-1992
T2. Studies of empiric and pre-emptive therapy

Explore the full IDWeek 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Washington. Leave your work email and we’ll be in touch.

Privacy

Download the full IDWeek 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Moffitt Cancer Center

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by IDWeek, the Infectious Diseases Society of America (IDSA) or its partner societies (SHEA, HIVMA, PIDS and SIDP). Submit a correction